Ultrasound Guided Steroids Injection Versus PRP for Shoulder Pain Relief
NCT ID: NCT05317624
Last Updated: 2023-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
60 participants
INTERVENTIONAL
2021-08-10
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corticosteroid Versus PRP Injections for Shoulder Tendinopathy
NCT07094178
Comparison of Hyaluronic Acid, PRP and Steroid Injections in Partial Rotator Cuff Tears: A Prospective Randomized Study
NCT04681937
Platelet Rich Plasma and Supraspinatus Tear
NCT03942679
Platelet Rich Plasm Versus Hyaluronic Acid Injection in Chronic Painful Shoulder
NCT05072899
Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair
NCT05603468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
30 patient in each group will be included
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Platelet rich plasma group
participants will receive Ultrasound guided subacromial injection of 3 ml platelet rich plasma+0.5 ml of PRP activator (10% calcium gluconate)+ 1ml 0.5%bupivacaine.
Platelet rich plasma
platelet rich plasma will be obtained from the particepants own blood mixed with activator and bupivacaine
Methylprednisolone group
participants will receive Ultrasound guided subacromial injection of 1 ml methylprednisolone+ 1ml 0.5%bupivacaine + 2.5 ml normal saline.
Methylprednisolone
1ml methyl prednisolone 40mg\\ml mixed with normal saline and bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Platelet rich plasma
platelet rich plasma will be obtained from the particepants own blood mixed with activator and bupivacaine
Methylprednisolone
1ml methyl prednisolone 40mg\\ml mixed with normal saline and bupivacaine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with positive radiological (US or MRI) findings of partial rotator cuff tear
Exclusion Criteria
2. Age less than 20 years.
3. Infection at injection site.
4. Prior surgery on the shoulder joint area.
5. Presence of other associated pathology in the shoulder joint
6. Patients using antiplatelet drugs (aspirin).
7. Contraindications to the use of platelet concentrate
8. Contraindications to the steroids injection
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
radwa saber
Radwa saber
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dorreya Fikry
Role: PRINCIPAL_INVESTIGATOR
AlexandriaUniversity
Tarek Sarhan
Role: STUDY_DIRECTOR
AlexandriaUniversity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Facility of medicine
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0201491
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.